Nevada adopts NAC 453.510 Schedule I additions: dipentylone and seven fentanyl-related substances (R107-25)

Nevada State Board of Pharmacy adoption package (R107-25) amends NAC 453.510 (Schedule I) to add dipentylone and seven specified fentanyl-related substances to Nevada’s controlled substances schedules, aligning state controls with federal scheduling actions as described in the informational statement. Compliance impact: entities operating in Nevada that handle controlled substances (e.g., laboratories, research/analytical standard suppliers, forensic and law-enforcement partners, regulated healthcare/pharmacy operations) must treat these newly listed substances as Schedule I under Nevada law (enhanced restrictions on possession/handling, licensing/registration controls, and related compliance program updates).